Antibody aggregation severely impacts a biopharmaceutical product’s efficacy and safety. Hence, an array of techniques are used to assess the physiochemical stability of candidate therapeutic ...
Refeyn, developer of pioneering mass photometry technology, expands its global adoption across contract research organizations (CROs) and contract development and manufacturing organizations (CDMOs).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results